Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-19 Sale | 2021-07-20 8:49 pm | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 3,944 | $6.45 | $25,439 | 146,362 (Indirect Direct) | View |
| 2021-01-05 Sale | 2021-01-07 5:56 pm | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 6,829 | $11.13 | $76,007 | 119,767 (Indirect Direct) | View |
| 2020-01-03 Sale | 2020-01-07 4:33 pm | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 3,724 | $0 | $0 | 56,061 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-29 Option Award | 2024-03-04 5:25 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Wentworth Kerry CHIEF REGULATORY OFFICER | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:57 pm | N/A 2033-02-27 | Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-08-29 Option Award | 2022-08-31 5:18 pm | N/A 2032-08-28 | Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer | 252,000 | $0 | 252,000 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 4:36 pm | N/A 2032-05-22 | Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer | 577,500 | $0 | 577,500 (Direct) | View |
Ownership | 2022-05-25 4:35 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer | 0 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:04 am | N/A 2024-11-02 | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 185,833 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:04 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 146,843 | $8.5 | 0 (Direct) | View |
| 2021-06-21 Option Award | 2021-06-28 6:09 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 539 | $7.78 | 150,306 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 6:35 pm | N/A 2031-02-28 | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 50,000 | $0 | 169,767 (Direct) | View |
| 2020-07-16 Option Award | 2020-07-20 9:23 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 38,750 | $0 | 126,180 (Direct) | View |
| 2020-06-22 Option Award | 2020-06-24 4:09 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 369 | $10.83 | 87,430 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:18 pm | N/A 2030-03-01 | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 46,500 | $0 | 102,561 (Direct) | View |